Trust Company of Vermont’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14K | Hold |
150
| – | – | ﹤0.01% | 947 |
|
|
2025
Q1 | $4.25K | Hold |
150
| – | – | ﹤0.01% | 867 |
|
|
2024
Q4 | $6.24K | Sell |
150
-300
| -67% | -$12.5K | ﹤0.01% | 825 |
|
|
2024
Q3 | $30.1K | Sell |
450
-50
| -10% | -$3.34K | ﹤0.01% | 592 |
|
|
2024
Q2 | $59.4K | Hold |
500
| – | – | ﹤0.01% | 469 |
|
|
2024
Q1 | $53.3K | Hold |
500
| – | – | ﹤0.01% | 481 |
|
|
2023
Q4 | $49.7K | Hold |
500
| – | – | ﹤0.01% | 431 |
|
|
2023
Q3 | $51.6K | Hold |
500
| – | – | ﹤0.01% | 453 |
|
|
2023
Q2 | $60.8K | Hold |
500
| – | – | ﹤0.01% | 463 |
|
|
2023
Q1 | $76.8K | Hold |
500
| – | – | 0.01% | 427 |
|
|
2022
Q4 | $89.8K | Hold |
500
| – | – | 0.01% | 399 |
|
|
2022
Q3 | $59K | Hold |
500
| – | – | ﹤0.01% | 465 |
|
|
2022
Q2 | $71K | Buy |
+500
| New | +$71K | 0.01% | 432 |
|
|
2022
Q1 | – | Sell |
-500
| Closed | -$127K | – | 592 |
|
|
2021
Q4 | $127K | Buy |
+500
| New | +$127K | 0.01% | 370 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$117K | – | 569 |
|
|
2021
Q2 | $117K | Hold |
500
| – | – | 0.01% | 378 |
|
|
2021
Q1 | $65K | Buy |
500
+60
| +14% | +$7.8K | ﹤0.01% | 436 |
|
|
2020
Q4 | $46K | Hold |
440
| – | – | ﹤0.01% | 458 |
|
|
2020
Q3 | $31K | Buy |
440
+300
| +214% | +$21.1K | ﹤0.01% | 484 |
|
|
2020
Q2 | $9K | Buy |
+140
| New | +$9K | ﹤0.01% | 636 |
|